欢迎访问《标记免疫分析与临床》官方网站!
临床研究

早期肥胖相关性肾病患者的血清胱抑C水平研究

展开
  • 航空总医院内分泌科, 北京 100012
周艳(1979-),女,硕士,主治医师。 Tel:13810467189

收稿日期: 2014-10-14

  修回日期: 2014-10-30

  网络出版日期: 2015-03-11

Study on the Serum Cystatin C in Patients with Early Obesity Related Glomerulopathy

Expand
  • Department of Endocrinology, Aviation General Hospital, Beijing 100012, China

Received date: 2014-10-14

  Revised date: 2014-10-30

  Online published: 2015-03-11

摘要

目的 通过测定早期肥胖相关性肾病患者的血清胱抑素C水平,探讨其与尿白蛋白排泄的关系。方法 选择在我院住院治疗的肥胖相关性肾病患者30例,门诊就诊的单纯肥胖者20例,以我院体检中心30名健康体检者作为对照者。采用免疫比浊法测定入选者血清的胱抑素C水平,并应用放射免疫分析法测定尿白蛋白排泄。结果 早期肥胖相关性肾病组及单纯肥胖组血清胱抑素C水平高于对照组(P <0.01),早期肥胖相关性肾病组血清胱抑素C水平与单纯肥胖组比较差异有统计学意义 (P <0.01)。早期肥胖相关性肾病组血清胱抑素C水平与尿白蛋白排泄呈正相关。结论 血清胱抑素C测定对肥胖相关性肾病的早期肾损伤具有重要的诊断价值。

本文引用格式

周 艳,张 田,王春艳,丁 智,苏 波,郑志荣,王志兴 . 早期肥胖相关性肾病患者的血清胱抑C水平研究[J]. 标记免疫分析与临床, 2015 , 22(2) : 92 . DOI: 10.11748/bjmy.issn.1006-1703.2015.02.004

Abstract

Objective To explore the serum level of Cystatin C (CysC) and its relationship with urinary albumin excretion (UAE) in patients with obesity related glomerulopathy. Methods 30 obesity patients with early obesity related glomerulopathy and 20 obesity patients without complication were enrolled in the study. 30 health check-up individuals were selected as control group. The levels of the serum CysC and UAE were measured by nephelometry and radioimmunoassay respectively. Results The levels of serum CysC in early obesity related glomerulopathy patients were significantly higher than those of the control group (P <0.01). There was a significant difference on serum CysC levels between early obesity related glomerulopathy group and simple obesity group. The serum level of Cys C was positively correlated with UAE in patients with early obesity related glomerulopathy. Conclusion The serum CysC levels can be a sensitive indicator to reflect the early stage damage in patients with early obesity related glomerulopathy.
文章导航

/